Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Co-Diagnostics, Inc. - Common Stock (NQ:CODX)

0.2519 -0.0298 (-10.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,191,034
Open 0.2500
Bid (Size) 0.2475 (59)
Ask (Size) 0.2535 (60)
Prev. Close 0.2817
Today's Range 0.2422 - 0.2543
52wk Range 0.2275 - 2.230
Shares Outstanding 33,712,530
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Thursday's pre-market session: top gainers and losers
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill

Performance

YTD
-65.1%
-65.1%
1 Month
-15.5%
-15.5%
3 Month
-24.6%
-24.6%
6 Month
-67.5%
-67.5%
1 Year
-79.5%
-79.5%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Earnings Scheduled For May 8, 2025
Via Benzinga
Examining the Future: Co-Diagnostics's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Uncovering Potential: Co-Diagnostics's Earnings Preview
Via Benzinga
Peering Into Co-Diagnostics's Recent Short Interest
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For March 27, 2025
Via Benzinga
Co-Diagnostics: Q4 Earnings Insights
Via Benzinga
Top movers in Tuesday's after hours session
Via Chartmill
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 14, 2024
Via Benzinga

Frequently Asked Questions

Is Co-Diagnostics, Inc. - Common Stock publicly traded?
Yes, Co-Diagnostics, Inc. - Common Stock is publicly traded.
What exchange does Co-Diagnostics, Inc. - Common Stock trade on?
Co-Diagnostics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Co-Diagnostics, Inc. - Common Stock?
The ticker symbol for Co-Diagnostics, Inc. - Common Stock is CODX on the Nasdaq Stock Market
What is the current price of Co-Diagnostics, Inc. - Common Stock?
The current price of Co-Diagnostics, Inc. - Common Stock is 0.2519
When was Co-Diagnostics, Inc. - Common Stock last traded?
The last trade of Co-Diagnostics, Inc. - Common Stock was at 07/10/25 04:00 PM ET
What is the market capitalization of Co-Diagnostics, Inc. - Common Stock?
The market capitalization of Co-Diagnostics, Inc. - Common Stock is 8.49M
How many shares of Co-Diagnostics, Inc. - Common Stock are outstanding?
Co-Diagnostics, Inc. - Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.